H2-DMα-(/)- mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection

Journal of Experimental Medicine

Volumn 192, Issue 1, 2000, Pages 31-40

  Felix, Nathan J ^a   June Brickey, W ^a   Griffiths, Robert ^b   Zhang, Jinghua ^a   Van Kaer, Luc ^c   Coffman, Thomas ^b   Ting, Jenny P Y ^a,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Alloreactivity; Class II associated antigenic peptide; H2 DM; Major histocompatibility complex class II; Transplantation

Indexed keywords

BETA 2 MICROGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; B LYMPHOCYTE ANTIGEN; CYTOKINE; H2 M ANTIGENS; H2-M ANTIGENS; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA D ANTIGEN; HLA DMB; HLA-DMB;

ALLOIMMUNITY; ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; GRAFT SURVIVAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; DBA MOUSE; GENETICS; HEART MUSCLE; HEART TRANSPLANTATION; IMMUNOLOGY; INVARIANT CHAIN; MOUSE MUTANT; MOUSE STRAIN; PHYSIOLOGY; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CYTOKINES; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, INBRED STRAINS; MICE, KNOCKOUT; MYOCARDIUM; TH1 CELLS; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034600568     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.192.1.31     Document Type: Article

References (61)

1. Gorer, P.A. 1937. The genetic and antigenic basis of tumor transplantation. J. Pathol. Bacteriol. 44:691.
2. Snell, G.D. 1948. Methods for the study of histocompatibility genes. J. Genet. 49:87.
3. Auchincloss, H., Jr., and H. Sultan. 1996. Antigen processing and presentation in transplantation. Curr. Opin. Immunol. 8:681-687.
4. Lim, S.M., D.J. White, and R.Y. Calne. 1987. Minor and class I MHC incompatibilities do not cause rejection of heart grafts but influence the rejection of skin grafts. Transplant. Proc. 19:4229-4230.
5. Stepkowski, S.M., A. Raza-Ahmad, and W.R. Duncan. 1987. The role of class I and class II MHC antigens in the rejection of vascularized heart allografts in mice. Transplantation. 44:753-759.
6. Campos, L., A. Naji, B.C. Deli, J.H. Kern, J.I. Kim, C.F. Barker, and J.F. Markmann. 1995. Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation. 59: 187-191.
7. Qian, S., F. Fu, Y. Li, L. Lu, A.S. Rao, T.E. Starzl, A.W. Thomson, and J.J. Fung. 1996. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Immunology. 88:124-129.
8. Bevan, M.J. 1984. High determinant density may explain the phenomenon of alloreactivity. Immunol. Today. 5:128.
9. Oldstone, M.B. 1987. Molecular mimicry and autoimmune disease. Cell. 50:819-820, [published erratum at 51:878].
10. Kourilsky, P., and J.M. Claverie. 1989. MHC-antigen interaction: what does the T cell receptor see? Adv. Immunol. 45: 107-193.
11. Sherman, L.A., and S. Chattopadhyay. 1993. The molecular basis of allorecognition. Annu. Rev. Immunol. 11:385-402.
12. Tallquist, M.D., and L.R. Pease. 1995. Alloreactive 2C T cells recognize a self peptide in the context of the mutant Kbm3 molecule. J. Immunol. 155:2419-2426.
13. Daniel, C., S. Horvath, and P.M. Allen. 1998. A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR. Immunity. 8:543-552.
14. Speir, J.A., K.C. Garcia, A. Brunmark, M. Degano, P.A. Peterson, L. Teyton, and I.A. Wilson. 1998. Structural basis of 2C TCK allorecognition of H-2Ld peptide complexes. Immunity. 8:553-562.
15. Zhao, R., D.J. Loftus, E. Appella, and E.J. Colins. 1999. Structural evidence of T cell xeno-reactivity in the absence of molecular mimicry. J. Exp. Med. 189:359-370.
16. Corr, M., A.E. Slanetz, L.F. Boyd, M.T. Jelonek, S. Khilko, B.K. al-Ramadi, Y.S. Kim, S.E. Maher, A.L. Bothwell, and D.H. Margulies. 1994. T cell reccptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science. 265: 946-949.
17. Sykulev, Y., A. Brunmark, M. Jackson, R.J. Cohen, P.A. Peterson, and H.N. Eisen. 1994a. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity. 1:15-22.
18. Sykulev, Y., A. Brunmark, T.J. Tsomides, S. Kageyama, M. Jackson, P.A. Peterson, and H.N. Eisen. 1994b. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. USA. 91:11487-11491.
19. Tallquist, M.D., T.J. Yun, and L.R. Pease. 1996. A single T cell receptor recognizes structurally distinct MHC-peptide complexes with high specificity. J. Exp. Med. 184:1017-1026.
20. Tallquist, M.D., A.J. Weaver, and L.R. Pease. 1998. Degenerate recognition of alloantigenic peptides on a positive-selecting class I molecule. J. Immunol. 160:802-809.
21. Rojo, S., D. Lopez, V. Calvo, and J.A. Lopez de Castro. 1991. Conservation and alteration of HLA-B27-specific T cell epitopes on mouse cells. Implications for peptide-mediated alloreactivity. J. Immunol. 146:634-642.
22. Villadangos, J.A., B. Galocha, and J.A. Lopez de Castro. 1994. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity. J. Immunol. 152:2317-2323.
23. Smith, P.A., A. Brunmark, M.R. Jackson, and T.A. Potter. 1997. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL). J. Exp. Med. 185:1023-1033.
24. Fung-Leung, W.P., C.D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P.A. Peterson, S.R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science. 271:1278-1281.
25. Martin, W.D., G.G. Hicks, S.K. Mendiratta, H.I. Leva, H.E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell. 84:543-550.
26. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements ot the MHC class II peptide-loading pathway. Cell. 84:531-541.
27. Lindstedt, R., M. Liljedahl, A. Peleraux, P.A. Peterson, and L. Karlsson. 1995. The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity. 3:561-572.
28. Denzin, L.K., N.F. Robbins, C. Carboy-Newcomb, and P. Cresswell. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity. 1:595-606.
29. Morris, P., J. Shaman, M. Attaya, M. Amaya, S. Goodman, C. Bergman, J.J. Monaco, and E. Mellins. 1994. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature. 368:551-554.
30. Fling, S.P., B. Arp, and D. Pious. 1994. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature. 368: 554-558.
31. Denzin, L.K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell. 82:155-165.
32. Sloan, V.S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D.M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature. 375:802-806.
33. Sherman, M.A., D.A. Weber, and P.E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity. 3:197-205.
34. Wolf, P.R., S. Tourne, T. Miyazaki, C. Benoist, D. Mathis, and H.L. Ploegh. 1998. The phenotype of H-2M-deficient mice is dependent on the MHC class II molecules expressed. Eur. J. Immunol. 28:2605-2618.
35. Stebbins, C.C., M.E. Peterson, W.M. Suh, and A.J. Sant. 1996. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules. J. Immunol. 157:4892-4898.
36. Stebbins, C.C., G.E. Loss, Jr., C.G. Elias, A. Chervonsky, and A.J. Sant. 1995. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J. Exp. Med. 181:223-234.
37. Brooks, A.G., P.L. Campbell, P. Reynolds, A.M. Gautam, and J. McCluskey. 1994. Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes. J. Immunol. 153:5382-5392.
38. Grubin, C.E., S. Kovats, P. deRoos, and A.Y. Rudensky. 1997. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class II-bound self-peptides. Immunity. 7:197-208.
39. Corry, R.J., H.J. Winn, and P.S. Russell. 1973. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation. 16:343-350.
40. Wunderlich, J., G. Shearer, and A. Livingstone. 1997. Assays for T cell function. In Current Protocols in Immunology. J. Coligan, A. Kruisbeek, D. Margulies, E. Shevach, and W. Strober, editors. John Wiley & Sons, Inc., New York. 3.11.1-3.11.20.
41. Dallman, M.J. 1995. Cytokines and transplantation: Th1/ Th2 regulation of the immune response to solid organ transplants in the adult. Curr. Opin. Immunol. 7:632-638.
42. Nickerson, P., W. Steurer, J. Steiger, X. Zheng, A.W. Steele, and T.B. Strom. 1994. Cytokines and the Th1/Th2 paradigm in transplantation. Curr. Opin. Immunol. 6:757-764.
43. Mendiratta, S.K., J.P. Kovalik, S. Hong, N. Singh, W.D. Martin, and L. Van Kaer. 1999. Peptide dependency of alloreactive CD4+ T cell responses. Int. Immunol. 11:351-360.
44. Bhardwaj, V., V. Kumar, H.M. Geysen, and E.E. Sercarz. 1993. Degenerate recognition of a dissimilar antigenic peptide by niyelin basic protein-reactive T cells. Implications for thymic education and autoimmunity. J. Immunol. 151:5000-5010.
45. Reay, P.A., R.M. Kantor, and M.M. Davis. 1994. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152:3946-3957.
46. Evavold, B.D., J. Sloan-Lancaster, K.J. Wilson, J.B. Rothbard, and P.M. Allen. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity. 2:655-663.
47. Wucherpfennig, K.W., and J.L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:695-705.
48. Kaliyaperumal, A., C. Mohan, W. Wu, and S.K. Datta. 1996. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183:2459-2469.
49. Kersh, G.J., and P.M. Allen. 1996. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J. Exp. Med. 184:1259-1268.
50. Mason, D. 1998. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today. 19: 395-404.
51. Ghosh, P., M. Amaya, E. Mellins, and D.C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature. 378:457-462.
52. Wu, S., J. Gorski, D.D. Eckels, and D.K. Newton-Nash. 1996. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. Effects of conservative amino acid substitutions at anchor position 1 of influenza matrix protein 19-31. J. Immunol. 156: 3815-3820.
53. Tourne, S., T. Miyazaki, A. Oxenius, L. Klein, T. Fehr, B. Kyewski, C. Benoist, and D. Mathis. 1997. Selection of a broad repertoire of CD4+ T cells in H-2Ma0/0 mice. Immunity. 7:187-195.
54. Basil, D., C.B. Williams, and P.M. Allen. 1998. In vivo antagonism of a T cell response by an endogenously expressed liquid. Proc. Natl. Acad. Sci. USA. 95:14332-14336.
55. Markinann, J.F., H. Bassiri, N.M. Desai, J.S. Odorico, J.I. Kim, B.H. Koller, O. Smithies, and C.F. Barker. 1992. Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. Transplantation. 54:1085-1089.
56. Osorio, R.W., N.L. Ascher, R. Jaenisch, C.E. Freise, J.P. Roberts, and P.G. Stock. 1993. Major histocompatibility complex class I deficiency prolongs islet allograft survival. Diabetes. 42:1520-1527.
57. Grusby, M.J., H. Auchincloss, Jr., R. Lee, R.S. Johnson, J.P. Spencer, M. Zijlstra, R. Jaenisch, V.E. Papaioannou, and L.H. Glimcher. 1993. Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl. Acad. Sci. USA. 90:3913-3917.
58. Auchincloss, H., Jr., R. Lee, S. Shea, J.S. Markowitz, M.J. Grusby, and L.H. Glimcher. 1993. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Prof. Natl. Acad. Sci. USA. 90:3373-3377.
59. Peugh, W.N., R.A. Superina, K.J. Wood, and P.J. Morris. 1986. The role of H-2 and non-H-2 antigens and genes in the rejection of murine cardiac allografts. Immunogenetics. 23: 30-37.
60. Wang, Y.C., A. Mayne, K.W. Sell, and A. Ahmed-Ansari. 1990. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue. Transplantation. 50:313-324.
61. Bishop, D.K., L.A. DeBruyne, S. Chan, S. Xu, and E.J. Eichwald. 1995. Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsiveness. Transpl. Immunol. 3:222-228.